References
- CLL Trialists' Collaborative Group. (1999) "Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials", Journal of National Cancer Institute, 91(10), 861–868.
- Foon, K.A. and Gale, R.P. (1987) "Staging and therapy of chronic lymphocytic leukemia", Seminar in Hematology, 24(4), 264–274.
- Hansen, M.M., Andersen, E., Christensen, BE., Christiansen, I., Geisler, C., Kristensen, D., et al. (1998) "CHOP versus prednisolone + Chlorambucil in chronic lymphocytic leukemia (CLL): pre-liminary results of a randomized multicenter study", Nouvelle Revue Francaise D Hematologie, 30(5–6), 433–436.
- Keating, Mi., Kantarjian, H., Talpaz, M., Redman, J., Koller, C., Barlogie, B., et al. (1989 ) "Fludarabine: a new agent with major activity against chronic lymphocytic leukemia", Blood, 74(1), 19— 25.
- Keating, M.J., O'Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., et al. (1998) "Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving Fludarabine regi-mens as initial therapy", Blood, 92(4), 1165 — 1171.
- Rai, KR., Perterson, B.L., Appelbaum, FR., Kolitz, J., Elias, L., Shepherd, L., et al. (2000) "Fludarabine compared with Chlor-ambucil as primary therapy for chronic lymphocytic leukemia", New England Journal of Medicine, 343, 1750 — 1757.
- Morrison, V.A., Rai, KR., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, FR., et al. (2001) "Impact of therapy with Chlor-ambucil, Fludarabine or Fludarabine plus Chlorambucil on infection in patients with chronic lymphocytic leukemia : intergroup study Cancer and Leukemia Group B 9011", Journal of Clinical Oncology, 19, 3611–3621.
- Leporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Feugier, P., Desablens, B., et al., for the French Coorperative Group on Chronic Lymphocytic Leukemia. (2001) "Randomized comparison of Fludarabine, CAP and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients", Blood, 98, 2319 — 2325.
- The French Cooperative Group on CLL, Johnson, S., Smith, AG., Loftier, H., Osby, E., Juliusson, G., Emmerich, B., et al. (1996) "Multicenter prospective randomized trial of Fludarabine versus Cyclophosphamide, doxorubicin and prednisone (CAP) for treat-ment of advanced-stage chronic lymphocytic leukemia", Lancet, 347, 1432— 1438.
- EORTC Leukemia Cooperative Group. (1999) "A randomized phase II trial of high -dose Chlorambucil vs Fludarabine in patients with advanced B-chronic lymphocytic leukemia", Hematololgy and Cell Therapy, 41, 127 — 136.
- Schmitt, B.F., Kneba, M., Ritgen, M., Stauch, M., Emmerich, B., Bergmann, M., et al. (2002) "First line therapy of patients with advanced chronic lymphocytic leukemia older than 65 years with Fludarabine versus Chlorambucil : interim analysis of a phase III study of the German CLL study group (GCLLSG)", American Society of Hematology, Abstract #1501
- Spriano, M., Chiurazzi, F., Cassibba, V., Leoni, P., Liso, V., Mazza, P., et al. (1998) "Multicentric prospective randomized trial of Fludarabine versus Chlorambucil and prednisolone in previously untreated patients with active B-chronic lymphocytic leukemia : first interim report", British Journal of Haematology, 102(14), 191.
- Jaksic, B., Brugiatelli, M., Sucin, S., Beaumelou, E., Wijermans, P.W., Belhabri, A., et al. for the EORTC Leukemia Group (2000) "Fludarabine vs high dose chlorambucil in advanced B cell chronic lymphocytic leukemia: results of EORTC phase II randomized trial after 4 years of median follow up", American Society of Hematology, Abstract #3280
- Cheson, B.D., Bennett, J.M., Greyer, M., Kay, N., Keating, Mi., O'Brien, S., and Rai, K.R. (1996) "National Cancer Institute - sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment", Blood, 87, 4990–4997.